Circulating cell-free DNA for cancer early detection
Q Gao, Q Zeng, Z Wang, C Li, Y Xu, P Cui, X Zhu, H Lu… - The Innovation, 2022 - cell.com
Effective screening modalities are currently available for only a small subset of cancers, and
they generally have suboptimal performance with complicated procedures. Therefore, there …
they generally have suboptimal performance with complicated procedures. Therefore, there …
Global epidemiology, prevention, and management of hepatocellular carcinoma
LY Mak, V Cruz-Ramón, P Chinchilla-López… - American Society of …, 2018 - ascopubs.org
The incidence rate of hepatocellular carcinoma (HCC) is rising. It is one of the most common
cancers worldwide and accounts for substantial morbidity and mortality. Chronic hepatitis B …
cancers worldwide and accounts for substantial morbidity and mortality. Chronic hepatitis B …
[HTML][HTML] Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Methods ChatGPT's responses to 164 questions were independently graded by two
transplant hepatologists and resolved by a third reviewer. The performance of ChatGPT was …
transplant hepatologists and resolved by a third reviewer. The performance of ChatGPT was …
Retracted: IL‐6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma
Z Yin, T Ma, Y Lin, X Lu, C Zhang… - Journal of cellular …, 2018 - Wiley Online Library
Human cancers, including hepatocellular carcinoma (HCC), are characterized by a high
degree of drug resistance in chemotherapy. However, the underlying molecular mechanism …
degree of drug resistance in chemotherapy. However, the underlying molecular mechanism …
FUT8 alpha-(1, 6)-fucosyltransferase in cancer
Aberrant glycosylation is a universal feature of cancer cells that can impact all steps in
tumour progression from malignant transformation to metastasis and immune evasion. One …
tumour progression from malignant transformation to metastasis and immune evasion. One …
Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis
In hepatocellular carcinoma (HCC), the signal transducer and activator of transcription 3
(STAT3) is present in an overactive state that is closely related to tumour development and …
(STAT3) is present in an overactive state that is closely related to tumour development and …
[HTML][HTML] lncRNA involvement in hepatocellular carcinoma metastasis and prognosis
Eukaryotic lncRNAs are RNA molecules defined to be greater than 200 bp in length that are
not translated to a protein and operate through several mechanisms, including participating …
not translated to a protein and operate through several mechanisms, including participating …
[HTML][HTML] Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, which in
turns accounts for the sixth most common cancer worldwide. Despite being the 6 th most …
turns accounts for the sixth most common cancer worldwide. Despite being the 6 th most …
Sphingolipids in non-alcoholic fatty liver disease and hepatocellular carcinoma: ceramide turnover
J Simon, A Ouro, L Ala-Ibanibo, N Presa… - International Journal of …, 2019 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) has emerged as one of the main causes of chronic
liver disease worldwide. NAFLD comprises a group of conditions characterized by the …
liver disease worldwide. NAFLD comprises a group of conditions characterized by the …
[HTML][HTML] Hepatocellular carcinoma: Where are we?
R Mazzanti, U Arena, R Tassi - World journal of experimental …, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the second cause of death due to malignancy in the
world, following lung cancer. The geographic distribution of this disease accompanies its …
world, following lung cancer. The geographic distribution of this disease accompanies its …